
Find Reports
Select Report Type
Reimbursement Review
Displaying 1401 - 1422 of 1422
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 2076 - 2100 of 2132
Please scroll or swipe to the right to view the full content.
Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
---|---|---|---|---|---|---|---|
Travoprost and timolol maleate | Reimbursement Review | Complete | SR0057-000 | ||||
Trospium chloride | Reimbursement Review | Complete | SR0055-000 | ||||
Voriconazole | Reimbursement Review | Complete | SR0056-000 | ||||
Pantoprazole magnesium | Reimbursement Review | Complete | SR0054-000 | ||||
Alefacept | Reimbursement Review | Complete | SR0053-000 | ||||
Triptorelin pamoate | Reimbursement Review | Complete | SR0051-000 | ||||
Treprostinil sodium | Reimbursement Review | Complete | SR0052-000 | ||||
Pegvisomant | Reimbursement Review | Complete | SR0050-000 | ||||
Insulin detemir | Reimbursement Review | Complete | SR0049-000 | ||||
Tipranavir | Reimbursement Review | Complete | SR0047-000 | ||||
Amlodipine besylate/ atorvastatin calcium | Reimbursement Review | Complete | SR0048-000 | ||||
Quinagolide hydrochloride | Reimbursement Review | Complete | SR0046-000 | ||||
Efalizumab | Reimbursement Review | Complete | SR0043-000 | ||||
Pegaptanib sodium | Reimbursement Review | Complete | SR0044-000 | ||||
Niacin/lovastatin | Reimbursement Review | Complete | SR0042-000 | ||||
Insulin aspart/insulin aspart protamine | Reimbursement Review | Complete | SR0041-000 | ||||
Omalizumab | Reimbursement Review | Complete | SR0045-000 | ||||
Tenofovir disoproxil fumarate | Reimbursement Review | Complete | SR0040-000 | ||||
Escitalopram oxalate | Reimbursement Review | Withdrawn | SR0039-000 | ||||
Abacavir/lamivudine | Reimbursement Review | Complete | SR0038-000 | ||||
Erlotinib | Reimbursement Review | Complete | SR0037-000 | ||||
Pregabalin | Reimbursement Review | Complete | SR0036-000 | ||||
Omalizumab | Reimbursement Review | Cancelled | SR0035-000 | ||||
Mycophenolate sodium | Reimbursement Review | Complete | SR0034-000 | ||||
Insulin glargine (rDNA origin) | Reimbursement Review | Complete | SR0033-000 |